skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion

Journal Article · · Virology
 [1];  [1];  [1];  [1];  [2]
  1. Gladstone Institute of Virology and Immunology, University of California, San Francisco, CA 94141-9100 (United States)
  2. Gladstone Institute of Virology and Immunology, University of California, San Francisco, CA 94141-9100 (United States) and Department of Medicine, University of California, San Francisco, CA 94141-9100 (United States) and Department of Microbiology and Immunology, University of California, San Francisco, CA 94141-9100 (United States)

We recently described a sensitive and specific assay that detects the fusion of HIV-1 virions to a broad range of target cells, including primary CD4 cells. This assay involves the use of virions containing {beta}-lactamase-Vpr (BlaM-Vpr) and the loading of target cells with CCF2, a fluorogenic substrate of {beta}-lactamase. Since Vpr strongly associates with the viral core, uncoating of the viral particle might be required for effective cleavage of CCF2 by BlaM-Vpr. Here, we show that BlaM-Vpr within mature viral cores effectively cleaves CCF2, indicating that this assay measures virion fusion independently of uncoating. We also show that wildtype and Nef-deficient HIV-1 virions fuse with equivalent efficiency to HeLa-CD4 cells, SupT1 T cells, and primary CD4 T cells. Since Nef enhances cytoplasmic delivery of viral cores and increases viral infectivity, these findings indicate that Nef enhances an early post-fusion event in the multistep process of viral entry. Possible sites of Nef action include enlargement of the fusion pore, enhanced uncoating of viral particles, and more efficient passage of viral cores through the dense cortical actin network located immediately beneath the plasma membrane.

OSTI ID:
20634880
Journal Information:
Virology, Vol. 328, Issue 1; Other Information: DOI: 10.1016/j.virol.2004.07.015; PII: S0042-6822(04)00467-2; Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0042-6822
Country of Publication:
United States
Language:
English